Toth Financial Advisory’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.3M Buy
128,684
+30,000
+30% +$2.68M 1.3% 19
2026
Q1
$7.09M Buy
98,684
+9,093
+10% +$700K 0.78% 48
2025
Q4
$7.11M Buy
89,591
+17,784
+25% +$1.4M 0.77% 49
2025
Q3
$5.41M Buy
71,807
+10,352
+17% +$709K 0.58% 60
2025
Q2
$4.24M Buy
61,455
+24,306
+65% +$1.59M 0.49% 70
2025
Q1
$2.52M Buy
37,149
+4,846
+15% +$290K 0.3% 94
2024
Q4
$1.45M Sell
32,303
-16,105
-33% -$903K 0.17% 110
2024
Q3
$3.04M Sell
48,408
-18,698
-28% -$1.09M 0.36% 90
2024
Q2
$3.96M Sell
67,106
-13,353
-17% -$835K 0.5% 71
2024
Q1
$6.42M Buy
80,459
+1,740
+2% +$133K 0.8% 47
2023
Q4
$6.22M Sell
78,719
-6,434
-8% -$458K 0.84% 42
2023
Q3
$5.95M Sell
85,153
-2,083
-2% -$148K 0.91% 41
2023
Q2
$6.03M Sell
87,236
-1,144
-1% -$81.4K 0.87% 40
2023
Q1
$6.57M Sell
88,380
-1,731
-2% -$145K 1.02% 35
2022
Q4
$8.4M Buy
90,111
+1,096
+1% +$106K 1.36% 20
2022
Q3
$8.49M Buy
89,015
+1,513
+2% +$150K 1.54% 15
2022
Q2
$8.11M Buy
87,502
+5,947
+7% +$580K 1.41% 19
2022
Q1
$8.25M Sell
81,555
-6,917
-8% -$727K 1.23% 22
2021
Q4
$9.13M Buy
88,472
+2,952
+3% +$273K 1.24% 22
2021
Q3
$7.26M Buy
85,520
+8,000
+10% +$670K 1.1% 30
2021
Q2
$6.47M Buy
77,520
+10,255
+15% +$840K 0.99% 37
2021
Q1
$5.06M Buy
67,265
+10,322
+18% +$752K 0.81% 44
2020
Q4
$3.89M Buy
56,943
+6,192
+12% +$403K 0.67% 56
2020
Q3
$2.96M Buy
50,751
+1,084
+2% +$67.5K 0.57% 62
2020
Q2
$3.23M Buy
49,667
+4,293
+9% +$270K 0.7% 51
2020
Q1
$2.69M Sell
45,374
-3,191
-7% -$213K 0.78% 50
2019
Q4
$3.61M Buy
48,565
+4,610
+10% +$324K 0.73% 50
2019
Q3
$2.77M Buy
43,955
+8,447
+24% +$501K 0.61% 59
2019
Q2
$1.94M Sell
35,508
-55,207
-61% -$2.97M 0.43% 68
2019
Q1
$4.89M Sell
90,715
-4,354
-5% -$269K 1.15% 33
2018
Q4
$6.23M Sell
95,069
-4,625
-5% -$345K 1.7% 18
2018
Q3
$7.85M Buy
99,694
+11,747
+13% +$840K 1.74% 13
2018
Q2
$5.66M Buy
87,947
+734
+0.8% +$48.4K 1.33% 28
2018
Q1
$5.42M Sell
87,213
-1,706
-2% -$122K 1.32% 27
2017
Q4
$6.45M Sell
88,919
-2,067
-2% -$150K 1.53% 20
2017
Q3
$7.4M Buy
90,986
+1,678
+2% +$133K 1.87% 12
2017
Q2
$7.19M Sell
89,308
-1,106
-1% -$87.3K 1.88% 10
2017
Q1
$7.1M Sell
90,414
-150
-0.2% -$12K 1.89% 11
2016
Q4
$7.15M Sell
90,564
-656
-0.7% -$53.1K 2.05% 10
2016
Q3
$8.12M Sell
91,220
-1,422
-2% -$134K 2.38% 6
2016
Q2
$8.87M Sell
92,642
-620
-0.7% -$61.8K 2.71% 4
2016
Q1
$9.67M Sell
93,262
-864
-0.9% -$84K 3.16% 1
2015
Q4
$9.2M Buy
94,126
+784
+0.8% +$76.8K 3.05% 2
2015
Q3
$9.01M Sell
93,342
-1,480
-2% -$156K 3.3% 2
2015
Q2
$9.95M Sell
94,822
-2,971
-3% -$304K 3.32% 1
2015
Q1
$10.1M Sell
97,793
-15,163
-13% -$1.53M 3.38% 2
2014
Q4
$10.9M Sell
112,956
-1,084
-1% -$95.5K 3.77% 1
2014
Q3
$9.08M Buy
114,040
+455
+0.4% +$35.9K 3.43% 1
2014
Q2
$8.56M Buy
113,585
+386
+0.3% +$29.2K 3.25% 2
2014
Q1
$8.47M Buy
113,199
+1,749
+2% +$124K 3.43% 1
2013
Q4
$7.98M Buy
111,450
+2,832
+3% +$182K 3.38% 1
2013
Q3
$6.16M Buy
108,618
+2,505
+2% +$149K 2.89% 3
2013
Q2
$6.07M Buy
+106,113
New +$6.15M 2.99% 2

Other funds holding CVS

Toth Financial Advisory's CVS Position: Q2 2026 in Review

Toth Financial Advisory increased its CVS Health (CVS) stake by 30% in Q2 2026, buying an estimated $2.68M and bringing the position to 128,684 shares worth $13.3M. The position accounts for 1.3% of the portfolio, ranked #19.

Toth Financial Advisory first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 443 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Toth Financial Advisory held 128,684 shares of CVS Health worth $13.3M as of Q2 2026.
  • Toth Financial Advisory bought 30,000 CVS Health shares in Q2 2026, an estimated $2.68M.
  • CVS Health made up 1.3% of Toth Financial Advisory's portfolio in Q2 2026, its #19 holding.
  • Toth Financial Advisory first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 443 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.